Cargando…

Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting

Pyoderma gangrenosum (PG) is a relatively rare inflammatory skin disease that progressively causes necrotic ulceration mainly on the lower extremities and trunk. Systemic corticosteroid is considered a first-line treatment for PG as it facilitates wound healing; however, several cases where tumor ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Hiroyuki, Okada, Yoshimoto, Watanabe, Seimi, Danno, Kanako, Yamamoto, Shinya, Ishiura, Ryohei, Nakayama, Yuichi, Mitsui, Kohei, Ueki, Ayaka, Nakai, Yasuo, Narushima, Mitsunaga, Yamanaka, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613544/
https://www.ncbi.nlm.nih.gov/pubmed/34899231
http://dx.doi.org/10.1159/000519659
_version_ 1784603664230383616
author Goto, Hiroyuki
Okada, Yoshimoto
Watanabe, Seimi
Danno, Kanako
Yamamoto, Shinya
Ishiura, Ryohei
Nakayama, Yuichi
Mitsui, Kohei
Ueki, Ayaka
Nakai, Yasuo
Narushima, Mitsunaga
Yamanaka, Keiichi
author_facet Goto, Hiroyuki
Okada, Yoshimoto
Watanabe, Seimi
Danno, Kanako
Yamamoto, Shinya
Ishiura, Ryohei
Nakayama, Yuichi
Mitsui, Kohei
Ueki, Ayaka
Nakai, Yasuo
Narushima, Mitsunaga
Yamanaka, Keiichi
author_sort Goto, Hiroyuki
collection PubMed
description Pyoderma gangrenosum (PG) is a relatively rare inflammatory skin disease that progressively causes necrotic ulceration mainly on the lower extremities and trunk. Systemic corticosteroid is considered a first-line treatment for PG as it facilitates wound healing; however, several cases where tumor necrosis factor-α inhibitors, adalimumab and infliximab, were administered showed good response. For intractable PG with a large ulcer or problematic epithelization, chemical or mechanical debridement of necrotic tissue in combination with skin grafting may be necessary to promote wound healing. Our report presents a case of intractable ulcerative PG requiring oral prednisolone and skin grafting. Although mechanical debridement was performed, granulation was poor; therefore, after the PG activity became quiescent, we utilized a vacuum-assisted closure (VAC) system to promote granulation and adaptation of the grafted skin. Although more cases are required for a definitive conclusion, the VAC system may be a choice for PG with large ulcers.
format Online
Article
Text
id pubmed-8613544
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-86135442021-12-09 Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting Goto, Hiroyuki Okada, Yoshimoto Watanabe, Seimi Danno, Kanako Yamamoto, Shinya Ishiura, Ryohei Nakayama, Yuichi Mitsui, Kohei Ueki, Ayaka Nakai, Yasuo Narushima, Mitsunaga Yamanaka, Keiichi Case Rep Dermatol Single Case Pyoderma gangrenosum (PG) is a relatively rare inflammatory skin disease that progressively causes necrotic ulceration mainly on the lower extremities and trunk. Systemic corticosteroid is considered a first-line treatment for PG as it facilitates wound healing; however, several cases where tumor necrosis factor-α inhibitors, adalimumab and infliximab, were administered showed good response. For intractable PG with a large ulcer or problematic epithelization, chemical or mechanical debridement of necrotic tissue in combination with skin grafting may be necessary to promote wound healing. Our report presents a case of intractable ulcerative PG requiring oral prednisolone and skin grafting. Although mechanical debridement was performed, granulation was poor; therefore, after the PG activity became quiescent, we utilized a vacuum-assisted closure (VAC) system to promote granulation and adaptation of the grafted skin. Although more cases are required for a definitive conclusion, the VAC system may be a choice for PG with large ulcers. S. Karger AG 2021-10-21 /pmc/articles/PMC8613544/ /pubmed/34899231 http://dx.doi.org/10.1159/000519659 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Goto, Hiroyuki
Okada, Yoshimoto
Watanabe, Seimi
Danno, Kanako
Yamamoto, Shinya
Ishiura, Ryohei
Nakayama, Yuichi
Mitsui, Kohei
Ueki, Ayaka
Nakai, Yasuo
Narushima, Mitsunaga
Yamanaka, Keiichi
Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_full Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_fullStr Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_full_unstemmed Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_short Successful Treatment of Ulcerative-Type Pyoderma Gangrenosum with a Combination Therapy of Oral Prednisolone, Vacuum-Assisted Closure, and Skin Grafting
title_sort successful treatment of ulcerative-type pyoderma gangrenosum with a combination therapy of oral prednisolone, vacuum-assisted closure, and skin grafting
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613544/
https://www.ncbi.nlm.nih.gov/pubmed/34899231
http://dx.doi.org/10.1159/000519659
work_keys_str_mv AT gotohiroyuki successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT okadayoshimoto successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT watanabeseimi successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT dannokanako successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT yamamotoshinya successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT ishiuraryohei successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT nakayamayuichi successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT mitsuikohei successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT uekiayaka successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT nakaiyasuo successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT narushimamitsunaga successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting
AT yamanakakeiichi successfultreatmentofulcerativetypepyodermagangrenosumwithacombinationtherapyoforalprednisolonevacuumassistedclosureandskingrafting